Cargando…

Interventional therapies for hepatocellular carcinoma

Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-gui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willatt, Jonathon M., Francis, Isaac R., Novelli, Paula M., Vellody, Ranjith, Pandya, Amit, Krishnamurthy, V.N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	e-Med 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335329/ https://www.ncbi.nlm.nih.gov/pubmed/22487698 http://dx.doi.org/10.1102/1470-7330.2012.0011

Ejemplares similares

Temporary Placement of Stent Grafts in Postsurgical Benign Biliary Strictures: a Single Center Experience
por: Vellody, Ranjith, et al.
Publicado: (2011)

Imaging of hepatocellular carcinoma and image guided therapies - how we do it
por: Willatt, Jonathon, et al.
Publicado: (2017)

Imaging and management of the incidentally discovered renal mass
por: Willatt, Jonathon, et al.
Publicado: (2009)

Preoperative splenic artery embolization in klippel-Trenaunay syndrome with massive splenomegaly: A case report
por: Zhang, Zishu, et al.
Publicado: (2014)

Acute Renal Artery Occlusion with Prolonged Renal Ischemia: A Case of Successful Treatment with Stent Placement and Catheter-directed Thrombolysis
por: Arabi, Mohammad, et al.
Publicado: (2011)

Endovascular treatment of thrombosed inferior vena cava filters: Techniques and short-term outcomes
por: Arabi, Mohammad, et al.
Publicado: (2015)

The indeterminate adrenal lesion
por: Sahdev, Anju, et al.
Publicado: (2010)

CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster
por: Pai, Deepa, et al.
Publicado: (2010)

Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma
por: Dasse, Kathy Diener, et al.
Publicado: (2016)

Small bowel volvulus around caesarian section scar adhesions
por: Wright, Adam, et al.
Publicado: (2017)

Aortic quadfurcation with persistent left sciatic artery: an extremely rare anatomic variant in a 3-year-old boy
por: Ho, Anthony, et al.
Publicado: (2021)

Interventional nanotheranostics in hepatocellular carcinoma
por: Chavda, Vivek P., et al.
Publicado: (2023)

Editorial: Interventional therapy of hepatocellular carcinoma
por: Ji, Jiansong, et al.
Publicado: (2022)

Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
por: Kim, Dong-Hyun
Publicado: (2022)

Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
por: Krishnamurthy, Shivani, et al.
Publicado: (2021)

Proton Therapy in the Management of Hepatocellular Carcinoma
por: Kobeissi, Jana M., et al.
Publicado: (2022)

Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
por: Storandt, Michael H, et al.
Publicado: (2022)

Neoadjuvant Therapy for Hepatocellular Carcinoma
por: Yin, Zongyi, et al.
Publicado: (2022)

First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination
por: Tella, Sri Harsha, et al.
Publicado: (2022)

New Tools for Molecular Therapy of Hepatocellular Carcinoma
por: Marchetti, Alessandra, et al.
Publicado: (2015)

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
por: Katariya, Nitin N., et al.
Publicado: (2022)

Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
por: Alqahtani, Ali, et al.
Publicado: (2019)

Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients()
por: Cuneo, Kyle C., et al.
Publicado: (2014)

How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
por: Fu, Yan, et al.
Publicado: (2023)

Targeted Therapy in Hepatocellular Carcinoma
por: Chua, Clarinda W. L., et al.
Publicado: (2011)

Radionuclide therapy of hepatocellular carcinoma
por: Sundram, FX
Publicado: (2006)

Targeted therapy for hepatocellular carcinoma
por: Huang, Ao, et al.
Publicado: (2020)

Evolving therapies in the treatment of hepatocellular carcinoma
por: Spangenberg, Hans Christian, et al.
Publicado: (2008)

Emerging therapies in advanced hepatocellular carcinoma
por: Medavaram, Sowmini, et al.
Publicado: (2018)

Immune cell therapy for hepatocellular carcinoma
por: Mizukoshi, Eishiro, et al.
Publicado: (2019)

Novel Cellular Therapies for Hepatocellular Carcinoma
por: Roddy, Harriet, et al.
Publicado: (2022)

Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma
por: Graur, Florin, et al.
Publicado: (2022)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Intraarterial Therapies for the Management of Hepatocellular Carcinoma
por: Garg, Tushar, et al.
Publicado: (2022)

New landscapes and horizons in hepatocellular carcinoma therapy
por: Cervello, Melchiorre, et al.
Publicado: (2020)

Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives
por: Girardi, Daniel M., et al.
Publicado: (2023)

Targeted antimicrobial therapy in the microbiome era
por: Stone, V.N., et al.
Publicado: (2017)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)

There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma
por: Wrighton, Paul J., et al.
Publicado: (2019)

The Role of Bridging Therapy in Hepatocellular Carcinoma
por: Galuppo, Roberto, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_scvo8u9lhigbsdg7jdiikt3mo2